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Summary
The primary cilium acts as a transducer of extracellular
stimuli into intracellular signaling [1, 2]. Its regulation,
particularly with respect to length, has been defined
primarily by genetic experiments and human disease states
in which molecular components that are necessary for its
proper construction have been mutated or deleted [1].
However, dynamic modulation of cilium length, a phenom-
enon observed in ciliated protists [3, 4], has not been well-
characterized in vertebrates. Here we demonstrate that
decreased intracellular calcium (Ca2+) or increased cyclic
AMP (cAMP), and subsequent protein kinase A activation,
increases primary cilium length in mammalian epithelial
andmesenchymal cells. Anterograde intraflagellar transport
is sped up in lengthened cilia, potentially increasing delivery
flux of cilium components. The cilium length response
creates a negative feedback loop whereby fluid shear-medi-
ated deflection of the primary cilium, which decreases intra-
cellular cAMP, leads to cilium shortening and thus
decreases mechanotransductive signaling. This adaptive
response is blocked when the autosomal-dominant poly-
cystic kidney disease (ADPKD) gene products, polycystin-
1 or -2, are reduced. Dynamic regulation of cilium length is
thus intertwined with cilium-mediated signaling and
provides a natural braking mechanism in response to
external stimuli that may be compromised in PKD.
Results and Discussion
To test the potential role of known signaling pathways in gov-
erning cilium length, we carried out a small-scale screen of
bioactive compounds with known targets to test their ability
to acutely increase cilium length (i.e., within 3 hr). Our screen
utilized the immortalized kidney collecting duct line (IMCD)
[5], embryonically derived kidney epithelia (MEK) [6], and
primary bone mesenchymal cells (BME) [7]. These cells were
chosen for their robust formation of primary cilia upon reach-
ing confluence in cell culture, as observed by indirect immuno-
fluorescence microscopy (Figure 1A; see also Figures S1A and
S1C available online). Two major classes of compounds*Correspondence: jagesh_shah@hms.harvard.eduemerged as potent stimulators of cilium length in all three
cell types: molecules directed at blocking Ca2+ entry into cells
or release of intracellular Ca2+ stores (e.g., Gd3+) and those
increasing intracellular cyclic AMP (cAMP) (e.g., forskolin [8]).
These compounds increased cilium length almost 2-fold in
3 hr (Figures 1A and 1B). In IMCD cells, cilia length increased
from 6.06 0.4 to 10.76 1.75 and 11.76 1.1 mm (mean6 stan-
dard deviation) after Gd3+ and forskolin treatment, respec-
tively. Similar results were seen in both MEK and BME cells
(Figure 1C; Figures S1B and S1D).
Using a number of compounds that modulate levels of intra-
cellular second messengers, we were able to further explore
the effect of Ca2+ and cAMP on cilium length (Figure 2A). The
ryanodine receptor inhibitor dantrolene, which acts to prevent
Ca2+ release, increased cilium length. In contrast, releasing
intracellular calcium stores (e.g., thapsigargin) or activation
of polycystin-2, a Ca2+-permeable, nonselective cation
channel, via triptolide [9] modestly decreased cilium length.
Use of a cAMP analog, 8-Br-cAMP, which directly activates
protein kinase A/cAMP-dependent kinase (PKA) also
increased cilium length. Conversely, a competitive inhibitor
of PKA activation Rp-cAMPS or direct inhibition of PKA by
H-89 or KT5720 resulted in shortening of the cilium (Figure 2A).
Thus, increasing intracellular cAMP and subsequent down-
stream activation of PKA acted to increase cilium length, and
inhibition of PKA activity reduced cilium length and the
converse observed for intracellular Ca2+.
Inhibition of phosphodiesterase activity had no significant
effect on cilium length (Figure S2A), indicating that a constitu-
tive cAMP degradation activity is not acting in these cells over
the time course of our experiment. Compounds targeting
cyclic guanosine nucleotide (cGMP)-mediated pathways did
not affect mammalian primary cilium length (Figure S2B), in
contrast to its effect on the morphology of nematode sensory
cilia [10].
The increase in cilium length did not require protein
synthesis because each drug was effective in the presence
of cycloheximide, a protein synthesis inhibitor (Figure S2C).
In addition, the length increase was reversed either by removal
of the drug after treatment (data not shown) or by chelation of
Gd3+ by addition of a stoichiometric concentration of ethylene
glycol tetraacetic acid (EGTA, 30 mM, much less than required
for Ca2+ chelation) after the initial length increase (Figure S2D).
To ascertain potential crosstalk between the signaling
pathways, we measured the levels of second messengers
directly after administration of the two most potent com-
pounds, forskolin and Gd3+. Measurements of steady-state
intracellular cAMP levels were increased 2-fold by Gd3+ and
6-fold by forskolin in comparison to untreated cells (Figure 2B).
Steady-state intracellular Ca2+ levels were reduced 43% and
37% when cells were treated with Gd3+ and forskolin, respec-
tively (Figure 2C). Together, these data reveal the crosstalk
between Ca2+ and cAMP and suggest that their coordinate
regulation modulates cilium length and that they may
converge on a common final effector.
Titration of the forskolin response with a specific PKA inhib-
itor prevented cilium lengthening, indicating that PKA is the
downstream element in the cAMP-mediated cilium length
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Figure 1. Modulation of Intracellular Cyclic AMP and Ca2+
Levels Alters Cilium Length
(A) Immortalized kidney collecting duct (IMCD) cells showed
an increase in cilium length after adenylyl cyclase activation
(100 mM forskolin) or inhibiting intracellular Ca2+ entry (30 mM
Gd3+) for 3 hr. Acetylated a-tubulin was used as a ciliary
marker (red). Scale bar represents 5 mm.
(B) Histograms of cilia length distribution in untreated and
treated IMCD cells (n > 150) show increased cilium length
in treated cells.
(C) Average length of cilia of IMCD, embryonically derived
kidney epithelia (MEK), and bone mesenchymal (BME) cells
were all significantly increased after drug treatment (*p <
0.001). Error bars indicate mean 6 standard deviation (SD).
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183regulation (Figure 2D; Figure S2E). PKA inhibition also pre-
vented Gd3+-induced cilium length increase. Conversely, thap-
sigargin suppressed the effect of forskolin cilium lengthening
but had no effect on 8-Br-cAMP-induced cilium lengthening
(10.96 6 1.09 and 9.32 6 1.59 mm under 8-Br-cAMP and
8-Br-cAMP plus thapsigargin incubation, respectively; Fig-
ure 2D; Figure S2F), indicating a potential role for Ca2+ modu-
lation of adenylyl cyclases (AC). To investigate the role of AC in
this pathway, we used short interfering RNAs to knock down
the expression of AC5 and AC6, two isoforms found in our
cell lines and inhibited by Ca2+ [11] (Figures S2G and S2H).
The siRNA-mediated knockdown of AC5 or AC6 blocked
cilium lengthening via Gd3+ (i.e., acting via Ca2+) but not via
8-Br-cAMP (i.e., direct PKA activation) (Figure 2E; Figure S2I).
These data are consistent with a signaling pathway in which
PKA activation, either directly via 8-Br-cAMP or indirectly via
AC activation, increases cilium length. This pathway is active
in cells of epithelial and mesenchymal origin, underscoring
a generalized control of primary cilium length in many tissues.
To investigate mechanisms by which PKA may regulate
cilium length, we observed the delivery of constituent proteins
to the cilium by imaging the intraflagellar transport (IFT)
machinery [12]. IFT particles are transported along axonemal
microtubules toward the cilium tip (anterograde) and removed
by transport toward the cell body (retrograde). Cilium length
regulation requires coordinate regulation of particle traf-
ficking, size, frequency, and speed to modulate the particle
flux [3]. We visualized IFT particle trafficking by labeling an
IFT component, IFT88, with enhanced yellow fluorescent
protein (EYFP) (Figures 3A and 3B; Movies S1–S3) [13]. Upon
addition of compounds to increase cilium length, anterograde
IFT88 particle velocities increased by w70%. In contrast,
there were no significant effects on retrograde velocities(Figures 3C–3E). Moreover, the lengthened cilia
displayed greater fluorescence at the tip, indi-
cating accumulation of IFT88 consistent with an
increased anterograde and unchanged retro-
grade velocities (Figure 3B). This increase in
anterograde velocity of transport, without a signif-
icant change in retrograde velocity, could result in
an increase in material flux into the cilium, thereby
leading to increased length. However, the material
flux is derived from a number of parameters such
as particle number, size, and occupancy that we
have not measured here, requiring a more
detailed analysis to understand the contribution
of increased anterograde velocity to the length
increase.The dynamic modulation of particle velocity has not previ-
ously been reported in mammalian cells (for Chlamydomonas,
see [14]) and represents a novel form of control for cargo trans-
port. One possible mechanism at work can be inferred from
studies of the nematode cilium where two motors, kinesin-II
and OSM3, both contribute to IFT but move at different veloc-
ities [15]. Ablation of kinesin-II, the slower motor (and in a
mutant Bardet-Biedl syndrome (bbs) background), results in
all IFT particles moving at the faster OSM3 velocity, and the
ablation of OSM3 (again in a bbs mutant background) results
in all IFT particles moving at the slower kinesin-II velocity. A
mechanism to dynamically titrate motor stoichiometries on
IFT particles could be used to regulate particle velocity. In
addition to motor-IFT composition, there may also exist
some enzymatic modulation of the motor itself or modification
of the microtubule track [16] that may impact IFT transport.
Recent work from Engel and colleagues [14] demonstrates
that motor velocity changes as a function of length in regener-
ating Chlamydomonas flagella after pH shock. Their work
suggests that flagellar length may itself be upstream of motor
velocity control rather than downstream. Further study will be
required to identify the underlying mechanisms of increased
anterograde IFT particle velocity.
The dynamic control of cilium length that we have observed
could provide a unique regulatory mechanism for the control of
sensitivity to extracellular cues. Given the similarity in coregu-
lation of intracellular Ca2+ and cyclic AMP between cilium
length control and flow mechanotransductive signaling [17,
18], we tested the effect of flow on cilium length. Primary cilia
in a number of tissues, most notably the kidney tubule and
hepatobiliary tree, transduce low-shear-stress fluid flow via
cilium deflection and Ca2+ influx [19]. After exposing kidney-
derived IMCD and MEK epithelial cells to 3 hr of shear stress
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Figure 2. Pathway Analysis of Second-
Messenger-Mediated Cilium-Length Increase
(A) Cilium length increased after blockade of Ca2+
entry (Gd3+), inhibition of Ca2+ release from
intracellular stores (dantrolene), and activation
of adenylyl cyclases (forskolin) or protein kinase
A (PKA) (8-Br-cAMP). Activation of Ca2+ signaling
by triptolide or thapsigargin or inhibition of PKA
signaling (Rp-cAMPS, KT-5270, H-89) resulted
in cilium length reduction. 1,9-dideoxy-forskolin
(Dideoxy-F) and dimethyl sulfoxide did not affect
cilium length. *p < 0.001, **p < 0.05. All treatments
were carried out for 3 hr.
(B) Gd3+ or forskolin treatment resulted in
increased intracellular cyclic AMP (cAMP). *p <
0.01, **p < 0.001.
(C) Steady-state levels of intracellular Ca2+ were
reduced under treatment of Gd3+ or forskolin.
(D) The inhibition of PKA coincident with Gd3+ or
forskolin treatment resulted in cilium length
reduction (*p < 0.05). Increasing intracellular
calcium (thapsigargin) suppressed the effect of
direct adenylyl cyclase activation (forskolin) on
cilium length but had no effect on the cilia length-
ening caused by the direct activation of PKA
(8-Br-cAMP). **p < 0.001.
(E) Silencing of AC5 or AC6 prevented cilium
lengthening in response to Gd3+ but not PKA
activation by 8-Br-cAMP. The bar graph repre-
sents the average length of cilia after 48 hr of
small interfering RNA (siRNA)-mediated knock-
down, followed by 3 hr of drug treatment. GAPDH
siRNA was used as a control for siRNA targeting.
n = 100 (*p < 0.001, **p < 0.05). Error bars indicate
mean 6 SD.
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184(0.75 dyne/cm2), we found that both untreated cells and
forskolin-treated cells had shorter cilia (20%–35%, p < 0.05)
(Figure 4A). Intracellular cyclic AMP levels were also signifi-
cantly decreased (1.5- to 3-fold) under flow, even in the pres-
ence of forskolin (as previously described by Masyuk and
colleagues [18]), and are consistent with the observed cilium
length reduction (Figure 4C). Similar results were also
observed in wild-type MEK cells (Figures 4B and 4D). The
effect of cilium length reduction would reduce the length of
the lever arm and decrease the sensitivity to fluid shear stress,
creating a previously unappreciated negative feedback loop to
adapt intracellular signaling to external cues.
Interestingly, Gd3+ treatment blocked the cilium length
decrease under flow and the reduction in cyclic AMP levels
(Figures 4C and 4D). The action of Gd3+ is rather promiscuous;
however, it has been shown to block the activity of polycystin-
2 (PC2), a transient receptor potential channel involved in Ca2+
entry under flow-mediated shear stress [20]. We investigated
the role of PC2 and its binding partner polycystin-1 (PC1) as
regulators of cilium length because both are known to regulate
flow mechanotransduction and are mutated in autosomal-
dominant forms of polycystic kidney disease (ADPKD) [21].
IMCD cells stably knocked down for PC2 (to w20% of wild-
type levels; Figure S3A) were subjected to flow but did not
exhibit the cilium length decrease as seen in their parental
counterparts under untreated conditions or forskolin addition
(Figure 4E). As expected from the lack of cilium length modu-
lation, these cells were unable to decrease cAMP levels under
flow (Figure 4G). Moreover, these cells exhibited a hyperactive
cAMP response to forskolin (w2.5-fold over wild-type cells)
that was maintained in the presence of flow. We tested the
role of PC1 via MEK cell lines generated from mice with a muta-
tion (del34) in the gene encoding for PC1 [6] (Figure S3B). Likethe PC2 knockdown cells, these cells did not exhibit cilium
shortening or a decrease in intracellular cyclic AMP under
flow, indicating a role for polycystins in cilium length adapta-
tion (Figures 4F and 4H). Notably, cells mutated for PC1 or
knocked down for PC2 all responded to forskolin in a similar
fashion to wild-type cells, with respect to cilium length, under
static conditions but did not undergo cilium length increase
upon administration of Gd3+. The response of wild-type cells
to Gd3+ might be expected to act like knockdown of PC1
and/or PC2, given the reduced Ca2+ level (Figures S3E and
S3F). However, there was no difference in untreated cilium
lengths for wild-type cells or cells with reduced PC1 and/or
PC2 function (Figures 4A and 4E). This suggests that cells
can adapt cilium length via an as-yet-unidentified mechanism
under chronic conditions (e.g., mutation or long-term knock-
down) but that acute perturbations of Ca2+ homeostasis
(e.g., via Gd3+ administration) modulate cilium length via the
activity of PC1 and/or PC2.
Dynamic cilium length regulation has been observed in
a number of unicellular ciliates, for example in Chlamydomo-
nas after deflagellation [4, 22]. However, the dramatic and
reversible cilium length increase seen here has not been previ-
ously studied in mammalian cells and even remains poorly
understood in unicellular ciliated organisms. The data pre-
sented here demonstrate that modulation of intracellular
Ca2+ and cyclic AMP and its downstream activation of PKA
controls cilium length in part by regulating IFT particle trans-
port velocity and possibly material anterograde flux. This
second-messenger-mediated control regulates cilium length
downstream of cellular signals such as flow-induced mecha-
notransduction, reducing sensitivity to fluid shear by
decreasing cilium length. The ADPKD proteins PC1 and PC2
regulate this adaptation, and in their absence, cells are
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Figure 3. Anterograde Intraflagellar Transport Velocities Increase under
Cilium Lengthening
(A) Visualization of the IFT88-EYFP particles in live IMCD cells revealed
a punctate distribution throughout the ciliary axoneme. White arrows high-
light particle movement (cilium tip, single arrowhead; basal body, double
arrowhead). Time is given in seconds. Scale bar represents 5 mm.
(B) Drug-treated cells show accumulation of IFT88 at the tips of primary cilia.
Scale bar represents 5 mm.
(C) To determine the intraflagellar transport particles’ velocities, we assem-
bled time-lapse image sequences into kymographs. White and black lines
on the kymograph indicate anterograde and retrograde velocities, respec-
tively. Length scale bar (horizontal) represents 5 mm. Time scale bar (vertical)
represents 5 s.
(D) Histograms of the particle velocity in untreated and drug-treated cells.
Negative velocities (left) represent retrograde particles, and positive veloc-
ities (right) indicate anterograde particles. Arrows represent mean velocity
in untreated cells.
(E) Ca2+ inhibition or AC activation increased anterograde velocity with no
significant effect on retrograde velocity. Error bars indicate mean 6 SD.
*p < 0.001.
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Figure 4. Cilium Length and cAMP Adaptation under Flow-Mediated Shear
Stress Depends on Polycystins
(A and B) Untreated cells subjected to fluid flow (shear stress 0.75 dyne/cm2)
(light gray bars, IMCD no flow; dark gray bars, MEK no flow; black bars, flow)
underwent a significant decrease in cilium length. Treatment with forskolin
in combination with flow also reduced cilium length. Fluid flow did not
suppress length increase caused by Gd3+.
(C and D) cAMP levels were reduced under flow condition in untreated wild-
type cells or those stimulated with forskolin. There was no change in cAMP
in Gd3+-treated cells under flow.
(E and F) Cilium length did not decrease under the application of flow to cells
knocked down for PC2 (IMCDPC2KD) or harboring a genetic mutation in PC1
(MEKPC1mut) (hatched bars, no flow; black bars, flow) in either untreated or
forskolin-treated cells. In addition, IMCDPC2KD and MEKPC1mut cells did
not increase cilium length in response to Gd3+.
(G and H) cAMP levels were unchanged after flow in IMCDPC2KD and
MEKPC1mut cells or in response to Gd3+. Error bars indicate mean 6 SD.
*p < 0.05, **p < 0.001.
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185unable to downregulate cAMP; thus, cilium length remains
unchanged.
This novel form of mechanical adaptation acts to modulate
the response to fluid shear and potentially other extracellular
cues. Polycystins act as a brake on signaling. In their absence,
signaling would continue unabated. The regulation of signaling
by flow-induced mechanotransduction has been widely
hypothesized as a mechanism that may be defective in PKD
Current Biology Vol 20 No 2
186[23]. Careful studies from Verghese and colleagues indicate
that renal tubular cilia length is modulated during various
forms of renal injury and repair ([24, 25] and our own unpub-
lished data), implicating dynamic length regulation as part of
a regenerative program. Given that these injury models them-
selves can act to potentiate cystogenesis in mouse models of
PKD [26–28], it is appealing to speculate that dynamic cilium
length regulation may be a part of an anticystogenic repair
program that, when absent, contributes to cystic pathology.
Experimental Procedures
Live-Cell Imaging of Intraflagellar Transport
Velocity measurements of IFT particles were performed as described previ-
ously [13]. Briefly, m368-4 cells (clonal line of IMCD cells stably expressing
IFT88-EYFP) were cultured on 18 mm poly-L-lysine-coated coverslips in
Dulbecco’s modified Eagle’s medium/10% fetal bovine serum. A confluent
monolayer of cells was subjected to IFT transport analysis by inversion onto
a large coverslip and a drop of CO2-independent media (Invitrogen) and was
imaged by high numerical aperture fluorescence microscopy on a TE2000
E2 inverted microscope system (Nikon) heated with an enclosed chamber
(In Vivo Scientific). Time-lapse images were captured by IPLab software
to a cooled charge-coupled device camera (CoolSNAP HQ, Roper Scien-
tific). Images were collected at 500–750 ms intervals with a PlanApo
603 NA 1.4 oil objective with exposure 200–500 ms at 2 3 2 binning. To
determine the IFT particles’ velocities, we assembled time-lapse image
sequences into kymographs with the ImageJ software package (http://
rsbweb.nih.gov/ij). IFT velocities were analyzed in control cells and cells
pretreated for 3 hr with the appropriate compound.
Cyclic AMP Measurements
Confluent murine IMCD and MEK cells were lysed in 0.1 M HCl. Lysed
samples were incubated at room temperature for 20 min. Samples were
then transferred to the centrifuge tubes and spun at maximum speed in
a tabletop microcentrifuge for 10 min. The supernatants were analyzed for
cAMP via a direct immunoassay kit (BioVision). The results were expressed
as pmol of cAMP per mg of protein. The protein concentration was deter-
mined by using Bradford protein assay kit (Pierce).
Statistical Analysis
Cilia length, IFT velocities, cAMP, and calcium measurements were
analyzed via one-way analysis ANOVA with OriginPro 7.5 (OriginLab). All
results were expressed as mean 6 standard deviation (data fromR3 inde-
pendent experiments). Results were considered significant at p < 0.05.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and three movies and can be found with this article
online at doi:10.1016/j.cub.2009.11.072.
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